|
5 Companies |
|
3 Products |
|
3 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
16 News |
|
- | tofacitinib / Generic mfg.
Trial completion: Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants (clinicaltrials.gov) - Jan 30, 2019
P2, N=10, Completed, Sponsor: Yale University
Active, not recruiting --> Completed
- | tofacitinib / Generic mfg.
Trial primary completion date: Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants (clinicaltrials.gov) - Jan 18, 2018
P2, N=10, Active, not recruiting, Sponsor: Yale University
Active, not recruiting --> Completed Trial primary completion date: Jul 2017 --> Jul 2018
- || Targretin gel (bexarotene topical) / Eisai, Bausch Health
Trial completion: Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata (clinicaltrials.gov) - Feb 22, 2014
P2/3, N=46, Completed, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Jul 2017 --> Jul 2018 No longer recruiting --> Completed
- Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Trial completion: The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis (clinicaltrials.gov) - Jul 31, 2012
P2/3, N=20, Completed, Sponsor: Siriraj Hospital
No longer recruiting --> Completed Not yet recruiting --> Completed